Literature DB >> 30470655

Transcranial color-coded sonography findings of patients with reversible cerebral vasoconstriction syndromes.

Yuka Terasawa1, Ayumi Arai2, Kenichiro Sakai2, Hidetaka Mitsumura2, Yasuyuki Iguchi2.   

Abstract

Reversible cerebral vasoconstriction syndromes (RCVS) have been well recognized recently as one cause of cerebrovascular disease, but the time course of vessel vasoconstriction remains uncertain. We report herein 2 cases with RCVS in which we clarified temporal changes in vessel vasoconstriction in detail using transcranial color-coded sonography (TCCS). The first case involved a 27-year-old woman who developed intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH) after severe headache. TCCS showed peak systolic velocity (PSV) in the left middle cerebral artery (MCA) peaked at 212 cm/s on day 6 and gradually decreased, whereas PSV of the left posterior cerebral artery (PCA) and left anterior cerebral artery (ACA) re-elevated to 190 cm/s on day 15. The second case involved a 53-year-old woman who developed cerebral infarction in the PCA territory 9 days after severe headache. TCCS study showed PSV elevation in the right MCA. Although TCCS seemed to normalize 7 days after admission, PSV of the left PCA, left ACA, and left MCA re-elevated at day 17. Both cases showed bimodal PSV peaks, with the posterior circulation peak preceded by the anterior circulation peak. These findings may be important in clarifying the mechanisms underlying vasoconstriction in patients with RCVS.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Reversible cerebral vasoconstriction syndromes; Transcranial color-coded sonography

Mesh:

Year:  2018        PMID: 30470655     DOI: 10.1016/j.jocn.2018.11.002

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  1 in total

1.  Chronic headache with vasospasm treated with nimodipine.

Authors:  Daniela Pimenta Silva; Maria Fátima Soares; Vanessa Almeida; Ana Catarina Fonseca
Journal:  J Neurol       Date:  2019-03-25       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.